Each substance misuse patient in shared care will have a personalised care plan based on the findings of a comprehensive nursing and GP assessment and supported by accompanying baseline investigations and diagnostics.

The care plan will be documented in the Electronic Patient Record (EPR) using the bespoke Drug Dependence Module on Systm 1 and shall contain goals and targets to be monitored at 3,6 and 12 months.

The nominated GP lead in the Practice for substance misuse shall work with the shared care team and members of the Practice multidisciplinary team to offer holistic care aimed at optimising maintenance treatment and tackling the determinants of illness. Clinical enhancements will include:

• The offer of a menu of structured bio psychosocial interventions delivered by a range of professionals from the Practice, WISMS and allied services.
• Nurse led well-being support interventions addressing smoking, alcohol, diet and exercise, mental well-being and sexual health.
• Links with outreach components of the Drugs Intervention Program.
• Potential for supplementary prescribing and access to pharmacy led consultations through a 100 hour surgery.
• Access to mainstream primary care services from GPs and Practice Nurses when consulting for a related condition, i.e. Depression, anxiety, DVT and chronic diseases.
• Offer of Hepatitis B screening, Hepatitis C screening and where appropriate and safe to do so Hepatitis C treatment with Interferon and pegalated Ribavarin thereby negating the need to attend at specialist hepatology centres.